Market Overview:
The global reproductive hormone market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The market is segmented by type, application, and region. By type, estrogen and progesterone, testosterone, and other hormones are the major segments of the market. Estrogen and progesterone are account for nearly 60% of the market share while testosterone accounts for about 10%. In terms of applications, hospitals and clinics account for about 90 percent of the market while other applications such as research laboratories accounted for a small share in 2017.
Product Definition:
A reproductive hormone is a type of hormone that is involved in the process of reproduction. Reproductive hormones are important for both men and women, as they play a role in the production of sperm and eggs, as well as in the development and function of reproductive organs.
Estrogen and Progesterone:
Estrogen and progesterone are the female and male hormones, produced by the ovary in response to the presence of a surge in Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). These hormones have wide applications in gynecology. Estrogen is used as an oral contraceptive for women; it works by decreasing the production of natural estrogen from fat cells.
Testosterone:
Testosterone is the male hormone and an anabolic agent. It plays a significant role in the growth & development of the fetus during pregnancy as well as in puberty. Testosterone also has a vital role in enhancing performance, muscle building, mood, sexual drive & function along with maintaining bone strength and hair growth.
The global testosterone market size was valued at USD 2 billion in 2015.
Application Insights:
In 2017, the clinics, other application segment accounted for a major market share. This is due to growing awareness about menopause and hormone replacement therapy among geriatric population and increasing incidences of climacteric syndrome in women. Moreover, an increase in the number of anti-aging clinics has boosted demand for HRT drugs across the globe. In addition, an increase in per capita income has enabled more women to work outside home which further increases demand for these hormones at retail pharmacies or online stores.
The hospitals segment is expected to witness lucrative growth over forecast period owing to rising prevalence of climacteric syndrome among middle-aged women along with increasing number of hysterectomies being performed annually as a result of unmet medical needs associated with menopause symptoms such as hot flashes and vaginal dryness among others’ symptoms are not relieved by conventional Hormone Replacement Therapy (HRT) drugs.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-established healthcare infrastructure, high awareness levels regarding available options for fertility treatment, and rising demand for natural and affordable products are some factors driving the regional market. Moreover, an increase in R&D initiatives by major players to develop novel therapies based on these hormones is expected to fuel growth during the forecast period.
Asia Pacific is estimated to be one of the fastest growing regions over the forecast period owing to a rise in population and increasing disposable income especially in developing countries such as China & India which will lead to an increased number of patients opting for hormonal therapy over coming years.
Growth Factors:
- Rising awareness about the benefits of reproductive hormones among women
- Increasing incidence of infertility and other reproductive health issues among women
- Growing demand for fertility treatments and products
- Proliferation of online retail platforms for selling reproductive hormones and related products
- Rising number of working women who are seeking to delay pregnancy or opt for contraception
Scope Of The Report
Report Attributes
Report Details
Report Title
Reproductive Hormone Market Research Report
By Type
Estrogen and Progesterone, Testosterone, Estrogen and progesterone are account for nearly 60% of market share., Reproductive Hormon
By Application
Hospitals, Clinics, Other, In applications, hospitals and clinics account for about 90 percent of the market.
By Companies
Pfizer, MERCK Groups, ABBVIE, Bayer, Endo Pharmaceuticals, Mayne Pharma, Jenapharm, Allergan, Noven Therapeutics, Xianju Pharma, Novo Nordisk, Zhejiang Aisheng, Reproductive Hormon
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Reproductive Hormone Market Report Segments:
The global Reproductive Hormone market is segmented on the basis of:
Types
Estrogen and Progesterone, Testosterone, Estrogen and progesterone are account for nearly 60% of market share., Reproductive Hormon
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Other, In applications, hospitals and clinics account for about 90 percent of the market.
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- MERCK Groups
- ABBVIE
- Bayer
- Endo Pharmaceuticals
- Mayne Pharma
- Jenapharm
- Allergan
- Noven Therapeutics
- Xianju Pharma
- Novo Nordisk
- Zhejiang Aisheng
- Reproductive Hormon
Highlights of The Reproductive Hormone Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Estrogen and Progesterone
- Testosterone
- Estrogen and progesterone are account for nearly 60% of market share.
- Reproductive Hormon
- By Application:
- Hospitals
- Clinics
- Other
- In applications, hospitals and clinics account for about 90 percent of the market.
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Reproductive Hormone Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Reproductive hormone is a term used to describe the hormones that are responsible for regulating reproduction in both men and women. These hormones include testosterone, estrogen, progesterone, and cortisone.
Some of the major companies in the reproductive hormone market are Pfizer, MERCK Groups, ABBVIE, Bayer, Endo Pharmaceuticals, Mayne Pharma, Jenapharm, Allergan, Noven Therapeutics, Xianju Pharma, Novo Nordisk, Zhejiang Aisheng, Reproductive Hormon.
The reproductive hormone market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Reproductive Hormone Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Reproductive Hormone Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Reproductive Hormone Market - Supply Chain
4.5. Global Reproductive Hormone Market Forecast
4.5.1. Reproductive Hormone Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Reproductive Hormone Market Size (000 Units) and Y-o-Y Growth
4.5.3. Reproductive Hormone Market Absolute $ Opportunity
5. Global Reproductive Hormone Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Reproductive Hormone Market Size and Volume Forecast by Type
5.3.1. Estrogen and Progesterone
5.3.2. Testosterone
5.3.3. Estrogen and progesterone are account for nearly 60% of market share.
5.3.4. Reproductive Hormon
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Reproductive Hormone Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Reproductive Hormone Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Other
6.3.4. In applications, hospitals and clinics account for about 90 percent of the market.
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Reproductive Hormone Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Reproductive Hormone Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Reproductive Hormone Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Reproductive Hormone Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Reproductive Hormone Demand Share Forecast, 2019-2026
9. North America Reproductive Hormone Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Reproductive Hormone Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Reproductive Hormone Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Other
9.4.4. In applications, hospitals and clinics account for about 90 percent of the market.
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Reproductive Hormone Market Size and Volume Forecast by Type
9.7.1. Estrogen and Progesterone
9.7.2. Testosterone
9.7.3. Estrogen and progesterone are account for nearly 60% of market share.
9.7.4. Reproductive Hormon
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Reproductive Hormone Demand Share Forecast, 2019-2026
10. Latin America Reproductive Hormone Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Reproductive Hormone Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Reproductive Hormone Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Other
10.4.4. In applications, hospitals and clinics account for about 90 percent of the market.
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Reproductive Hormone Market Size and Volume Forecast by Type
10.7.1. Estrogen and Progesterone
10.7.2. Testosterone
10.7.3. Estrogen and progesterone are account for nearly 60% of market share.
10.7.4. Reproductive Hormon
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Reproductive Hormone Demand Share Forecast, 2019-2026
11. Europe Reproductive Hormone Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Reproductive Hormone Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Reproductive Hormone Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Other
11.4.4. In applications, hospitals and clinics account for about 90 percent of the market.
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Reproductive Hormone Market Size and Volume Forecast by Type
11.7.1. Estrogen and Progesterone
11.7.2. Testosterone
11.7.3. Estrogen and progesterone are account for nearly 60% of market share.
11.7.4. Reproductive Hormon
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Reproductive Hormone Demand Share, 2019-2026
12. Asia Pacific Reproductive Hormone Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Reproductive Hormone Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Reproductive Hormone Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Other
12.4.4. In applications, hospitals and clinics account for about 90 percent of the market.
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Reproductive Hormone Market Size and Volume Forecast by Type
12.7.1. Estrogen and Progesterone
12.7.2. Testosterone
12.7.3. Estrogen and progesterone are account for nearly 60% of market share.
12.7.4. Reproductive Hormon
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Reproductive Hormone Demand Share, 2019-2026
13. Middle East & Africa Reproductive Hormone Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Reproductive Hormone Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Reproductive Hormone Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Other
13.4.4. In applications, hospitals and clinics account for about 90 percent of the market.
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Reproductive Hormone Market Size and Volume Forecast by Type
13.7.1. Estrogen and Progesterone
13.7.2. Testosterone
13.7.3. Estrogen and progesterone are account for nearly 60% of market share.
13.7.4. Reproductive Hormon
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Reproductive Hormone Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Reproductive Hormone Market: Market Share Analysis
14.2. Reproductive Hormone Distributors and Customers
14.3. Reproductive Hormone Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Pfizer
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. MERCK Groups
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. ABBVIE
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Bayer
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Endo Pharmaceuticals
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Mayne Pharma
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Jenapharm
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Allergan
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Noven Therapeutics
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Xianju Pharma
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Novo Nordisk
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Zhejiang Aisheng
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Reproductive Hormon
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
